Drug Pipeline

Ficerafusp alfa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT06788990
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With…		 Trial sites expanded: 161 -> 173 locations
2026-05-15 NCT06788990
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With…		 Trial sites expanded: 129 -> 161 locations
Active Studies by Phase
Phase 2/3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06788990 FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With… Metastatic Head and Neck Squamous Cell Carcinoma Recruiting
Phase 2
NCT07465276 Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting
NCT07529873 Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With… Squamous Cell Carcinoma of Head and Neck (SCCHN) Not Yet Recruiting
Phase 1/2
NCT07552558 Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and… Head and Neck Squamous Cell Carcinoma Not Yet Recruiting
Sponsors Running Ficerafusp alfa Trials
Bicara Therapeutics (1) Dana-Farber Cancer Institute (1) Groupe Oncologie Radiotherapie Tete et Cou (1) Washington University School of Medicine (1)
Disease Areas
Head & Neck Cancer (3)
Get alerts when Ficerafusp alfa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free